Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01761266 |
|---|---|
| Brief Title: | A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma |
| First Submitted : | January 2, 2013 |
| First Submitted that Met QC Criteria : | January 3, 2013 |
| First Posted : | January 4, 2013 (Estimate) |
| Results First Submitted : | August 27, 2018 |
| Results First Submitted that Met QC Criteria : | August 27, 2018 |
| Results First Posted : | September 25, 2018 |
| Certification/Extension First Submitted : | January 18, 2018 |
| Certification/Extension First Submitted that Met QC Criteria : | January 19, 2018 |
| Certification/Extension First Posted : | January 25, 2018 |
| Last Update Submitted that Met QC Criteria : | March 27, 2020 |
| Last Update Posted : | March 30, 2020 |